Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BENEFIT 15 long-term follow-up study
2017-001176-31Phase 4Completed
- Sponsor
- Bayer
- Start
- Jul 2017
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon beta-1b in clinically isolated syndrome (CIS) and multiple sclerosis (MS), sponsored by Bayer. Primary endpoints: Disease course over time, Relapse and 3 more. Started Jul 2017; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
clinically isolated syndrome (CIS)multiple sclerosis (MS)
Beyond the preview
Go deeper on 2017-001176-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001176-31.